Article
Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
Thrombosis and haemostasis - 1 Feb 2007
de Maat Moniek P M, Madsen Jonna Skov, Langdahl Bente, Bladbjerg Else Marie, Tofteng Charlotte Landbo, Abrahamsen Bo, Rejnmark Lars, Brixen Kim, Christensen Kaare, Jespersen Jørgen, Kristensen Søren Risom
Abstract excerpt
Markers of inflammation, such as C-reactive protein (CRP) and fibrinogen, are associated with the risk of atherothrombosis. Plasma levels of these markers of inflammation are affected by hormone replacement therapy (HRT) and modulated by smoking. We studied whether genetic variation in the estrogen receptor- 1 (ESR1), CRP and fibrinogen-beta genes influences the plasma levels of inflammation markers after HRT....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.